Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Cardinal Health Inc is a medical distribution business based in the US. Cardinal Health shares (CAH) are listed on the NYSE and all prices are listed in US Dollars. Cardinal Health employs 46,354 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$51.04|
|52-week range||$43.07 - $61.93|
|50-day moving average||$53.00|
|200-day moving average||$56.87|
|Wall St. target price||$57.79|
|Dividend yield||$1.949 (3.7%)|
|Earnings per share (TTM)||$2.08|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-15)||-3.73%|
|1 month (2021-08-20)||-0.68%|
|3 months (2021-06-22)||-9.97%|
|6 months (2021-03-22)||-13.70%|
|1 year (2020-09-22)||8.41%|
|2 years (2019-09-20)||6.58%|
|3 years (2018-09-21)||54.94|
|5 years (2016-09-22)||77.56|
Valuing Cardinal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardinal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cardinal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Cardinal Health shares trade at around 25x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cardinal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5181. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardinal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cardinal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 billion.
The EBITDA is a measure of a Cardinal Health's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$162.5 billion|
|Operating margin TTM||1.23%|
|Gross profit TTM||$7 billion|
|Return on assets TTM||2.92%|
|Return on equity TTM||34.13%|
|Market capitalisation||$15.3 billion|
TTM: trailing 12 months
There are currently 10.4 million Cardinal Health shares held short by investors – that's known as Cardinal Health's "short interest". This figure is 181% up from 3.7 million last month.
There are a few different ways that this level of interest in shorting Cardinal Health shares can be evaluated.
Cardinal Health's "short interest ratio" (SIR) is the quantity of Cardinal Health shares currently shorted divided by the average quantity of Cardinal Health shares traded daily (recently around 2.9 million). Cardinal Health's SIR currently stands at 3.65. In other words for every 100,000 Cardinal Health shares traded daily on the market, roughly 3650 shares are currently held short.
However Cardinal Health's short interest can also be evaluated against the total number of Cardinal Health shares, or, against the total number of tradable Cardinal Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cardinal Health's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Cardinal Health shares in existence, roughly 40 shares are currently held short) or 0.036% of the tradable shares (for every 100,000 tradable Cardinal Health shares, roughly 36 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cardinal Health.
Find out more about how you can short Cardinal Health stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Cardinal Health.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 12.66
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Cardinal Health's overall score of 12.66 (as at 12/31/2018) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Cardinal Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.25/100
Social score: 5.84/100
Governance score: 1.08/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Cardinal Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Cardinal Health hasn't always managed to keep its nose clean.
|Total ESG score||12.66|
|Total ESG percentile||6.34|
|Level of controversy||3|
Dividend payout ratio: 35.2% of net profits
Recently Cardinal Health has paid out, on average, around 35.2% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.72% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cardinal Health shareholders could enjoy a 3.72% return on their shares, in the form of dividend payments. In Cardinal Health's case, that would currently equate to about $1.949 per share.
While Cardinal Health's payout ratio might seem fairly standard, it's worth remembering that Cardinal Health may be investing much of the rest of its net profits in future growth.
Cardinal Health's most recent dividend payout was on 14 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2021 (the "ex-dividend date").
Cardinal Health's shares were split on a 3:2 basis on 22 April 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cardinal Health shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cardinal Health shares which in turn could have impacted Cardinal Health's share price.
Over the last 12 months, Cardinal Health's shares have ranged in value from as little as $43.0729 up to $61.9346. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cardinal Health's is 1.0497. This would suggest that Cardinal Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
Everything we know about the Volcon IPO, plus information on how to buy in.
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
Everything we know about the FGI Industries IPO, plus information on how to buy in.
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.